Gangnam Severance Hospital
- Country
- š°š·South Korea
- Ownership
- Private
- Established
- 1983-04-01
- Employees
- -
- Market Cap
- -
Clinical Trials
136
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (109 trials with phase data)ā¢ Click on a phase to view related trials
Comparison of Safety and Clinical Effects of Straight and Articulated Instruments (ArtiSential) in Laparoscopic Gastrectomy for Gastric Cancer Patients, a Prospective Randomized Study
- Conditions
- Gastric Adenocarcinoma Patients, Who Are Scheduled for Laparoscopic Radical Gastrectomy
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Gangnam Severance Hospital
- Target Recruit Count
- 76
- Registration Number
- NCT07100431
- Locations
- š°š·
GangnamSeverance Hospital, Seoul, Korea, Republic of
Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence Score
- Conditions
- Breast CancerTumor Grade
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Gangnam Severance Hospital
- Target Recruit Count
- 4000
- Registration Number
- NCT07093775
Darbepoetin Alfa Once Monthly Dosing Schedule Maintains Hemoglobin Concentration Comparable to Every 2 Weeks Dosing Schedule in Advanced Chronic Kidney Disease Patients Not on Dialysis, Multicenter, Phase 4 Study
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Gangnam Severance Hospital
- Target Recruit Count
- 77
- Registration Number
- NCT07025460
- Locations
- š°š·
Institutional Review Board, Gangnam Severance Hospitial Yonsei University College of Medicine, Seoul, Korea, Republic of
Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBC
- Conditions
- Triple-Negative Breast Neoplasm
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Gangnam Severance Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT07011823
Comparison of Full Robotic Instrumentation and Assistant-Controlled Laparoscopic Instrumentation in Robotic Distal Gastrectomy
- Conditions
- Gastric Cancer
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Gangnam Severance Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT06841484
- Locations
- š°š·
GangnamSeveranceHospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 28
- Next
News
Ovarian Function Suppression Enhances Survival in Select HER2-Positive Breast Cancer
ā¢ Exploratory analysis of the HERA trial reveals that ovarian function suppression (OFS) combined with endocrine therapy significantly improves long-term survival in premenopausal women with HER2-positive, hormone receptor-positive breast cancer. ā¢ The 10-year disease-free survival rate increased from 59.6% with tamoxifen alone to 70.9% with the addition of OFS, demonstrating a substantial benefit in disease control. ā¢ Overall survival rates at 10 years also saw a marked improvement, rising from 74.0% to 84.7% with the inclusion of OFS in the treatment regimen. ā¢ While OFS can be challenging due to toxicity, its use should be considered in selected high-risk patients to improve survival outcomes.